Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

Emergency Medicine Resident-Driven Point of Care Ultrasound for Suspected Shoulder Dislocation.

Boswell B, Farrow R, Rosselli M, Farcy DA, Santana L, Santos CD, Cubeddu LX.

South Med J. 2019 Dec;112(12):605-609. doi: 10.14423/SMJ.0000000000001046.

PMID:
31796968
2.

The Relationship Between Physician/Nurse Gender and Patients' Correct Identification of Health Care Professional Roles in the Emergency Department.

Boge LA, Dos Santos C, Moreno-Walton LA, Cubeddu LX, Farcy DA.

J Womens Health (Larchmt). 2019 Jul;28(7):961-964. doi: 10.1089/jwh.2018.7571. Epub 2019 May 31.

PMID:
31149867
3.

Patients' Perceptions of the Role of Physicians in Questioning and Educating in Firearms Safety: Post-FOPA Repeal Era.

Boge LA, Dos Santos C, Burkholder JD, Koschel BR, Cubeddu LX, Farcy DA.

South Med J. 2019 Jan;112(1):34-38. doi: 10.14423/SMJ.0000000000000915.

PMID:
30608630
4.

Breaking the Barriers in Resident Education: A Quality Improvement Initiative.

Cabarga LH, Cubeddu LX, Olickal J, Habibnejad S, Kury-Perez E, Pundhir P, Pirela D, Goldszer RC.

J Healthc Qual. 2018 Jul/Aug;40(4):e54-e61. doi: 10.1097/JHQ.0000000000000111.

PMID:
29252870
5.

Comparison of Performance Characteristics of Oval Cup Forceps Versus Serrated Jaw Forceps in Gastric Biopsy.

Sussman DA, Deshpande AR, Shankar U, Barkin JA, Medina AM, Poppiti RJ, Cubeddu LX, Barkin JS.

Dig Dis Sci. 2016 Aug;61(8):2338-2343. doi: 10.1007/s10620-016-4129-y. Epub 2016 Mar 22.

PMID:
27003145
7.

Association of traits of metabolic syndrome with glucose abnormalities.

Hoffmann IS, Cubeddu LX.

Am J Ther. 2013 Jul-Aug;20(4):363-8. doi: 10.1097/MJT.0b013e318235f2b8.

PMID:
23591026
8.

Prevalence of glucose abnormalities and diagnostic value of fasting glucose and fasting insulin in urban Hispanics.

Hoffmann IS, Alfieri AB, Cubeddu LX.

Am J Ther. 2013 Jul-Aug;20(4):369-75. doi: 10.1097/MJT.0b013e318235f2f5.

PMID:
23528370
9.

Impact of traits of metabolic syndrome on β-cell function and insulin resistance in normal fasting, normal glucose tolerant subjects.

Cubeddu LX, Hoffmann IS.

Metab Syndr Relat Disord. 2012 Oct;10(5):344-50. Epub 2012 Jul 17.

PMID:
22803772
10.

Metabolic syndrome: an all or none or a continuum load of risk?

Cubeddu LX, Hoffmann IS.

Metab Syndr Relat Disord. 2012 Feb;10(1):14-9. doi: 10.1089/met.2011.0058. Epub 2011 Oct 27.

PMID:
22032809
11.

Statin rebound or withdrawal syndrome: does it exist?

Pineda A, Cubeddu LX.

Curr Atheroscler Rep. 2011 Feb;13(1):23-30. doi: 10.1007/s11883-010-0148-x. Review.

PMID:
21104165
12.
13.

Iatrogenic QT Abnormalities and Fatal Arrhythmias: Mechanisms and Clinical Significance.

Cubeddu LX.

Curr Cardiol Rev. 2009 Aug;5(3):166-76. doi: 10.2174/157340309788970397.

14.

Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma.

Calderon RM, Cubeddu LX, Goldberg RB, Schiff ER.

Mayo Clin Proc. 2010 Apr;85(4):349-56. doi: 10.4065/mcp.2009.0365. Review.

15.

Microalbuminuria: do we need a new threshold?

Zamora CR, Cubeddu LX.

J Hum Hypertens. 2009 Feb;23(2):146-9. doi: 10.1038/jhh.2008.105. Epub 2008 Sep 11.

PMID:
18784737
16.

Salt and the metabolic syndrome.

Hoffmann IS, Cubeddu LX.

Nutr Metab Cardiovasc Dis. 2009 Feb;19(2):123-8. doi: 10.1016/j.numecd.2008.02.011. Epub 2008 Jun 16.

PMID:
18556187
17.
18.
19.

Upregulation of angiotensin II-AT1 receptors during statin withdrawal in vascular smooth muscle cells.

Castejon AM, Zollner E, Tristano AG, Cubeddu LX.

J Cardiovasc Pharmacol. 2007 Dec;50(6):708-11.

PMID:
18091590
20.

Effects of lifestyle changes and metformin on salt sensitivity and nitric oxide metabolism in obese salt-sensitive Hispanics.

Hoffmann IS, Alfieri AB, Cubeddu LX.

J Hum Hypertens. 2007 Jul;21(7):571-8. Epub 2007 Apr 26.

PMID:
17460713
21.

Increased blood pressure reactivity to dietary salt in patients with the metabolic syndrome.

Hoffmann IS, Cubeddu LX.

J Hum Hypertens. 2007 Jun;21(6):438-44. Epub 2007 Feb 1.

PMID:
17273153
22.

Effects of statin treatment and withdrawal on angiotensin II-induced phosphorylation of p38 MAPK and ERK1/2 in cultured vascular smooth muscle cells.

Tristano AG, Castejon AM, Castro A, Cubeddu LX.

Biochem Biophys Res Commun. 2007 Feb 2;353(1):11-7. Epub 2006 Nov 17.

PMID:
17161379
23.

Comparative lipid-lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial.

Cubeddu LX, Cubeddu RJ, Heimowitz T, Restrepo B, Lamas GA, Weinberg GB.

Am Heart J. 2006 Nov;152(5):982.e1-5.

PMID:
17070175
24.

Statin withdrawal: clinical implications and molecular mechanisms.

Cubeddu LX, Seamon MJ.

Pharmacotherapy. 2006 Sep;26(9):1288-96. Review.

PMID:
16945051
25.

NAD(P)H oxidase p22phox gene C242T polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics.

Castejon AM, Bracero J, Hoffmann IS, Alfieri AB, Cubeddu LX.

J Hum Hypertens. 2006 Oct;20(10):772-9. Epub 2006 Jun 1.

PMID:
16738684
26.

Endothelial nitric oxide synthase polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics.

Hoffmann IS, Tavares-Mordwinkin R, Castejon AM, Alfieri AB, Cubeddu LX.

J Hum Hypertens. 2005 Mar;19(3):233-40.

PMID:
15565175
27.

CYP11B2-CYP11B1 haplotypes associated with decreased 11 beta-hydroxylase activity.

Ganapathipillai S, Laval G, Hoffmann IS, Castejon AM, Nicod J, Dick B, Frey FJ, Frey BM, Cubeddu LX, Ferrari P.

J Clin Endocrinol Metab. 2005 Feb;90(2):1220-5. Epub 2004 Oct 26.

PMID:
15507509
28.

Alpha-adducin polymorphism, salt sensitivity, nitric oxide excretion, and cardiovascular risk factors in normotensive Hispanics.

Castejon AM, Alfieri AB, Hoffmann IS, Rathinavelu A, Cubeddu LX.

Am J Hypertens. 2003 Dec;16(12):1018-24.

PMID:
14643575
29.
30.

Ondansetron and metformin-induced gastrointestinal side effects.

Hoffmann IS, Roa M, Torrico F, Cubeddu LX.

Am J Ther. 2003 Nov-Dec;10(6):447-51.

PMID:
14624284
31.

Role of salt sensitivity, blood pressure, and hyperinsulinemia in determining high upper normal levels of urinary albumin excretion in a healthy adult population.

Cubeddu LX, Hoffmann IS, Aponte LM, Nuñez-Bogesits R, Medina-Suniaga H, Roa M, Garcia RS.

Am J Hypertens. 2003 May;16(5 Pt 1):343-9.

PMID:
12745194
32.

Lesion of caudate-putamen interneurons with kainic acid alters dopamine and serotonin metabolism in the olfactory tubercle of the rat.

Guevara BH, Torrico F, Hoffmann IS, Cubeddu LX.

Cell Mol Neurobiol. 2002 Dec;22(5-6):835-44.

PMID:
12585701
33.
34.
35.

Clustering of silent cardiovascular risk factors in apparently healthy Hispanics.

Hoffmann IS, Cubeddu LX.

J Hum Hypertens. 2002 Mar;16 Suppl 1:S137-41.

36.

Differential blood pressure effects of oral glucose and intravenous L-arginine in healthy lean normotensive and obese hypertensive subjects.

Castejon AM, Hoffmann IS, Jimenez E, Cubeddu RJ, Baldonedo RM, Cubeddu LX.

J Hum Hypertens. 2002 Mar;16 Suppl 1:S133-6.

37.

Insulin resistance and upper-normal glucose levels in hypertension: a review.

Cubeddu LX, Hoffmann IS.

J Hum Hypertens. 2002 Mar;16 Suppl 1:S52-5. Review.

39.

Nitric oxide synthases and cyclophosphamide-induced cystitis in rats.

Alfieri AB, Malave A, Cubeddu LX.

Naunyn Schmiedebergs Arch Pharmacol. 2001 Mar;363(3):353-7.

PMID:
11284451
40.
41.

Nitric oxide and NK(1)-tachykinin receptors in cyclophosphamide-induced cystitis, in rats.

Alfieri AB, Cubeddu LX.

J Pharmacol Exp Ther. 2000 Nov;295(2):824-9.

PMID:
11046124
42.

Nitric oxide and salt sensitivity.

Cubeddu LX, Alfieri AB, Hoffmann IS, Jimenez E, Roa CM, Cubeddu R, Palermo C, Baldonedo RM.

Am J Hypertens. 2000 Sep;13(9):973-9.

PMID:
10981546
43.

Insulin and blood pressure responses to changes in salt intake.

Cubeddu LX, Hoffmann IS, Jimenez E, Roa CM, Cubeddu RJ, Palermo C, Baldonedo RM.

J Hum Hypertens. 2000 Apr;14 Suppl 1:S32-5.

44.

Effects of short- and long-term exercise on urinary cGMP excretion in healthy subjects and in patients with coronary artery disease.

Alfieri AB, Rodriguez-Plaza LG, Cubeddu LX.

J Cardiovasc Pharmacol. 2000 Jun;35(6):891-6.

PMID:
10836723
45.

Role of NK1 receptors on cisplatin-induced nephrotoxicity in the rat.

Alfieri AB, Cubeddu LX.

Naunyn Schmiedebergs Arch Pharmacol. 2000 Mar;361(3):334-8.

PMID:
10731048
46.

Effects of metformin on intestinal 5-hydroxytryptamine (5-HT) release and on 5-HT3 receptors.

Cubeddu LX, Bönisch H, Göthert M, Molderings G, Racké K, Ramadori G, Miller KJ, Schwörer H.

Naunyn Schmiedebergs Arch Pharmacol. 2000 Jan;361(1):85-91.

PMID:
10651152
47.

Levels and molecular properties of secretoneurin-immunoreactivity in the serum and urine of control and neuroendocrine tumor patients.

Ischia R, Gasser RW, Fischer-Colbrie R, Eder U, Pagani A, Cubeddu LX, Lovisetti-Scamihorn P, Finkenstedt G, Laslop A, Winkler H.

J Clin Endocrinol Metab. 2000 Jan;85(1):355-60.

PMID:
10634410
50.

Supplemental Content

Loading ...
Support Center